Tahmid Khan

Tahmid Hasib Khan is a public health researcher and pharma communications strategist with deep expertise at the intersection of medical evidence, policy, and patient engagement. He advises pharmaceutical and healthtech clients on brand strategy, RWE storytelling, launch readiness, and advocacy alignment—especially across therapeutic areas like opioid use disorder, overdose reversal, immunology, oncology, and digital therapeutics. His portfolio includes work with Pfizer, Indivior, Sanofi Regeneron, USONA Institute, Midway Health Network, BARDA, and others. From filing-stage innovations to post-market access campaigns, Tahmid brings regulatory fluency and creative clarity to some of today’s most complex healthcare challenges.

He holds an MPH in Epidemiology from Columbia University and a BSc in Global Health from the University of Toronto. With additional leadership roles across cross-border healthcare initiatives and advocacy platforms, Tahmid is passionate about turning science into impact—especially for underrepresented populations and evolving regulatory landscapes. At Metli, he brings founder-level perspective to strategy, patient voice integration, and data-driven storytelling for pharma clients.